Skip to main content

19 April 2026

Last updated: Saturday 18 April 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

How developers approach antibody drug conjugates

Saturday 12 November 2011

Interviewee/Contributor

Bruno Pagliara

Organisation

On-kòs Pharma Consulting

Affimed brings new antibody to the clinic

Wednesday 15 September 2010

Interviewee/Contributor

Rolf Günther

Organisation

Affimed Therapeutics AG

Organisations

TI Pharma
Terumo Blood and Cell Technologies
Horizon Discovery Group Ltd
Oncology specialist Bruno Pagliara
ISA Pharmaceuticals BV
Sofinnova Partners
iTeos Therapeutics SA
Sen-Jam Pharmaceutical
Arecor Therapeutics Plc
European Medicines Agency

Interviewees and Contributers

Mark Vaeck
Antoine Papiernik
Jackie Turnbull and David Bates
Ruth McKernan
Iain Wilcock
William Sellers
Erich Tauber
Ali Mortazavi
Koenraad Wiedhaup
Bruno Pagliara and Vittore Tamassia

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Immunic appoints CNS expert to board

Thursday 16 April 2026

CEPI appoints board members

Thursday 16 April 2026

New CEO at Orano Med

Thursday 16 April 2026

Aravax names two board members

Thursday 16 April 2026

Poolbeg Pharma names drug developer to SAB

Saturday 14 March 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form